Results 121 to 130 of about 31,188 (302)

Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease [PDF]

open access: gold, 2021
Ciro De Luca   +7 more
openalex   +1 more source

Familial aggregation of migraine and depression: Insights from a large Australian twin sample [PDF]

open access: yes, 2016
Free to read\ud \ud Objectives: This research examined the familial aggregation of migraine, depression, and their co-occurrence.\ud \ud Methods: Diagnoses of migraine and depression were determined in a sample of 5,319 Australian twins.
Heath, Andrew C   +5 more
core   +3 more sources

Reduced Frequency of Prolonged Sporadic Hemiplegic Migraine Attacks Following Fremanezumab Treatment—A Case Report

open access: yesEuropean Journal of Neurology, Volume 33, Issue 2, February 2026.
A 64‐year‐old man was admitted to the stroke unit with acute aphasia and right‐sided hemiplegia, but imaging showed no signs of acute stroke. Symptoms gradually improved and fully resolved by Day 21, following the onset of a hemicranial headache. A diagnosis of sporadic hemiplegic migraine was made, and no further attacks occurred under fremanezumab ...
Julian Frederic Hotz   +9 more
wiley   +1 more source

Motor skills in children with primary headache: A pilot case-control study [PDF]

open access: yes, 2018
Background: Headache is the most common painful manifestation in the developmental age, often accompanied by severe disability such as scholastic absenteeism, low quality of academic performance and compromised emotional functioning. The aim of the study
Cerroni F.   +21 more
core   +1 more source

Cardiovascular Health Status, Migraine Risk, and Mortality Outcomes in Migraine Individuals: Insights From NHANES

open access: yesBrain and Behavior, Volume 16, Issue 1, January 2026.
Higher levels of cardiovascular health, as assessed by the Life's Simple 7 score, are associated with a reduced risk of incident migraine and are significantly linked to improved all‐cause and cardiovascular mortality outcomes among individuals with migraine.
Hongwei Liu   +6 more
wiley   +1 more source

Serial systemic immune inflammation indices: markers of acute migraine events or indicators of persistent inflammatory status?

open access: yesThe Journal of Headache and Pain
Background Migraine is the most common complex neurological disorder, affecting over a billion people worldwide. Neurogenic inflammation has long been recognized as a key factor in the pathophysiology of migraine though little research has been directed ...
Tissa Wijeratne   +8 more
doaj   +1 more source

Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. [PDF]

open access: yes, 2009
There is evidence that the prevalence of migraine in children and adolescents may be increasing. Current theories of migraine pathophysiology in adults suggest activation of central cortical and brainstem pathways in conjunction with the peripheral ...
A Ferrari   +52 more
core   +1 more source

Concurrent Reversible Cerebral Vasoconstriction Syndrome and Bilateral Vertebral Artery Dissection in the Postpartum Period: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Reports of postpartum women with concurrent reversible cerebral vasoconstriction syndrome (RCVS) and bilateral vertebral artery dissection (VAD) are rare. Guidelines on the management of future pregnancies in these patients are also limited.
Rong Jin   +2 more
wiley   +1 more source

Neuromodulation [PDF]

open access: yes, 2016
Neuromodulation is a new promising treatment for headache disorders. It consists of peripheral nerve neurostimulation and central neurostimulation. © 2016, Touch Briefings.
Silberstein, Stephen
core   +2 more sources

A Phase 1 Open‐Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults

open access: yesClinical Pharmacology in Drug Development, Volume 15, Issue 1, January 2026.
Abstract Zavegepant is the only calcitonin gene‐related peptide antagonist approved as a nasal spray in the United States for acute treatment of migraine in adults with or without aura. This Phase 1, open‐label study evaluated the pharmacokinetics, safety, and tolerability of a single intranasal dose of zavegepant 10 mg in 12 healthy Chinese adults ...
Qiong Wei   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy